Twist Bioscience Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

Twist Bioscience Corp reported Cash And Cash Equivalents At Carrying Value of $183.05 million for the year ending 2025.

  • Twist Bioscience Corp showed a decrease of -19.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 17, 2025.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Twist Bioscience Corp's Cash And Cash Equivalents At Carrying Value has grown by 486.2%.
  • Historical annual values: Fiscal year 2025: $183.05 million | Fiscal year 2024: $226.32 million | Fiscal year 2023: $286.47 million | Fiscal year 2022: $378.69 million | Fiscal year 2021: $465.83 million | Fiscal year 2020: $93.67 million | Fiscal year 2019: $46.74 million | Fiscal year 2018: $80.76 million | Fiscal year 2017: $31.23 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: